Britain aims to complete ‘ten million’ of Covid-19 vaccinations within the next three months, British Prime Minister Boris Johnson said on Sunday.
In an interview with the BBC, Johnson said: ‘We do hope we can make ten million [of Covid-19 vaccines] in the next three months I can definitely give you the figure, ”he added.
Johnson said that this strategy is based on three vaccines, the Pfizer / BioNTech vaccine and Oxford / AstraZeneca vaccines – both approved in the UK – and the Moderna vaccine which will soon be ready for use.
The prime minister, who said this in October last year, said: ‘I thought it would be better by spring. I stick to it. ”
Asked about the number of doses of the Oxford / AstraZeneca Covid-19 vaccine, which was approved by British regulators on Wednesday, Johnson said 530,000 doses would be ready to be vaccinated on Monday, in addition to ‘the million or so’. Pfizer / BioNTechCovid -19 vaccine already distributed.
Earlier on Sunday, British Health Minister Matt Hancock said on Twitter that the country had administered 1 million Pfizer / BioNTech Covid-19 vaccines, saying “the end is in sight.”
UK reviews vaccine lead Last week, UK chief medical officers issued revised advice on the recommended interval between doses for the coronavirus vaccine developed by Pfizer and BioNTech.
While UK regulators have previously recommended that a second dose of the Pfizer / BioNTech vaccine be given three weeks after the first dose, British medical officials have advised this week that it can be given between 3 and 12 weeks after the first dose. Similarly, the second dose of the newly authorized Oxford / AstraZeneca vaccine may be given 4 to 12 weeks after the first, according to the recommendations.
In a letter to healthcare professionals, the chief executive defended their decision to extend the interval period for patients waiting to receive their second dose of Pfizer / BioNTech vaccine and said on Thursday that the decision was made based on their assessed risk-benefit balance. . .
The British Medical Association said the move was “a thousand unfair” to thousands of at-risk patients across the country.
Pfizer says it has no data to show that just a single dose of its Covid-19 vaccine will provide protection against the disease after more than 21 days.